Health

iHerb Experiences Explosive Growth During COVID

PASADENA, Calif., Jan. 29, 2021 /PRNewswire/ -- iHerb is responding to explosive worldwide customer demand, including record-breaking U.S. sales, as people seek to boost their immunity, improve their health, and stay safe at home during the global COVID-19 pandemic that continues to worsen in man...

2021-01-29 19:00 3159

Mentice's CEO Goran Malmberg to present the company's year-end 2020 report at a webcast conference call on February 4 at 9:30 CET

STOCKHOLM, Jan. 29, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its year-end report via webcast conference call with the opportunity for interested parties to ask questions to CEOGoran Malmberg and CFOElisabet Lund. To register for the presentation of the ...

2021-01-29 18:36 2385

Nippon Express Bangladesh Obtains GDP Certification for Air Cargo Import/Export Services

TOKYO, Jan. 29, 2021 /PRNewswire/ -- Nippon Express Bangladesh Ltd. (hereinafter, "NE Bangladesh"), a local subsidiary of Nippon Express Co., Ltd. based inTokyo, has obtained Good Distribution Practice (GDP) certification effectiveSunday, December 13, 2020, evidencing its compliance with standard...

2021-01-29 15:00 1543

2021 Japan Prize Laureates Announced

TOKYO, Jan. 29, 2021 /PRNewswire/ -- The winners of the 2021 Japan Prize were announced onJanuary 29 by the Japan Prize Foundation and its president, Hiroshi Komiyama. The newest laureates are Australian researcher Prof. Martin Andrew Green, honored for his work in the field of "Resources, Energy...

2021-01-29 14:00 742

Ascentage Pharma Announces the Fifth Orphan Drug Designation Granted to Bcl-2 Inhibitor APG-2575 by the US FDA, and the Tenth Obtained by the Company

SUZHOU, China and ROCKVILLE, Md., Jan. 29, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug A...

2021-01-29 08:29 2126

12-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at LINC

NYON, Switzerland, Jan. 29, 2021 /PRNewswire/ -- 12-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Trial at LINC 2021. The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR™, MedAllianc...

2021-01-29 01:46 908

Alfasigma to expand its digital footprint

Online doctorAsyou, a web platform entirely dedicated to physicians The website optimizes research on the most important and autoritative medical databases such as Pubmed, ICTRP and ClinicalTrials.gov. An entirely new area presents online courses for physicians on several different topics BOLO...

2021-01-29 00:27 2903

RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals

TEL AVIV, Israel and RALEIGH, N.C., Jan. 28, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced a manufacturing agreement with Cosmo Pharmaceuticals NV (SIX: COPN) ("...

2021-01-28 22:03 5216

"Right to Work" Is Theme of 16th Global Appeal to End Stigma and Discrimination against Persons Affected by Leprosy to Be Launched with Endorsement of International Trade Union Confederation

TOKYO and BRUSSELS, Jan. 28, 2021 /PRNewswire/ -- The 16th Global Appeal to End Stigma and Discrimination against Persons Affected by Leprosy will be launched in an online ceremony onJanuary 31, 2021, World Leprosy Day. Global Appe...

2021-01-28 22:00 1337

Immunoforge's 'PF1801' Is Designated as Orphan Drug by FDA

SEOUL, South Korea, Jan. 28, 2021 /PRNewswire/ -- Immunoforge, the company specializing in the development of new drugs for rare musculoskeletal diseases (Representatives: An Seong-Min and Jang Gi-Ho), announced that their new drug candidate PF1801 has been designated as the FDA orphan drug for t...

2021-01-28 22:00 1915

Covid-T™ Clinical Development Program Initiated Regulatory Advisory Group Engaged

VANCOUVER, BC, Jan. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to announce that it has initiated the clinical development program for Covid-T™, the Company's novel diagnostic platform for detecting T-cell activity. T...

2021-01-28 21:46 5174

Zeus Launches Reinforced Polyimide Tubing

Expanded Capabilities Help Customers Consolidate Suppliers, Innovate, and Go to Market With Confidence ORANGEBURG, S.C., Jan. 28, 2021 /PRNewswire/ -- Zeus Industrial Products, Inc. (Zeus), a leading polymer solutions provider and material science innovator, announced today that it has added bra...

2021-01-28 21:00 1531

Technology Innovations and Virtual Consultations Drive the Healthcare Industry Transformation by 2025

SANTA CLARA, Calif., Jan. 28, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis,Vision 2025—Rising Healthcare Expenditures and Disproportionate Improvement in Patient Outcomes Spur Disruptive Changes in the Global Healthcare Industry, forecasts that global healthcare revenues in 2025 will ...

2021-01-28 20:52 1894

IDEXX and the Tuskegee University College of Veterinary Medicine Announce Landmark Initiative

Advancing diversity in veterinary medicine through nine full scholarships and integrated support WESTBROOK, Maine, Jan. 28, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, announced today a landmark initiative with theTuskegee...

2021-01-28 20:30 6015

Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil

SUZHOU, China, Jan. 28, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to announce that the clinical trial (the "Trial") of Proxalutamide's treatment of hospitalized COVID-19 patients was approved by the Institutional Review Board ("IRB") ofBrazil. The trial was accept...

2021-01-28 19:57 6245

CROMSOURCE Consolidates Strategic Site Support Service

VERONA, Italy, Jan. 28, 2021 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO), announced today the expansion of its Strategic Site Support Service that can be provided to sites participating in clinical research studies managed by CROMSOURCE on behalf of companies...

2021-01-28 19:00 2181

Sai Life Sciences announces plans to double headcount and expand capabilities in Manchester, UK

MANCHESTER, England and HYDERABAD, India, Jan. 28, 2021 /PRNewswire/ -- Sai Life Sciences, one ofIndia's fastest growing Contract Research, Development & Manufacturing Organizations  (C...

2021-01-28 15:30 2871

Envirotainer Opens 3rd Indian Station in Bangalore

UPPLANDS VÄSBY, Sweden, Jan. 28, 2021 /PRNewswire/ -- Envirotainer, the global market leader and by far the largest provider of secure cold chain solutions for air transport of pharmaceuticals, today announced that they are expanding their global station network by adding a third station inIndia,...

2021-01-28 15:27 1595

SC Johnson Partners With Habitat for Humanity to Provide Access to Housing, Clean Water and Sanitation across Asia Pacific

RACINE, Wis., Jan. 28, 2021 /PRNewswire/ -- In response to the unprecedented impact of the COVID-19 pandemic on underserved communities, SC Johnson is teaming with Habitat for Humanity to provide access to housing and proper water, sanitation and hygiene (WASH) facilities for hundreds of families...

2021-01-28 14:41 2149

Tencent Cloud raises the bar of crowd management through intelligent cloud solutions and AI technology suitable for all organizations

BANGKOK, Jan. 28, 2021 /PRNewswire/ -- Tencent Cloud, the cloud business of Tencent, today introduces its intelligent cloud solutions and artificial intelligence (AI) technology that could be leveraged for crowd management in the Southeast Asia amid the pandemic. The company offers a suite of solu...

2021-01-28 14:00 1819
1 ... 664665666667668669670 ... 858